MedTrace Logo

Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center

NCT01881971 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2020-10-08

No results posted yet for this study

Summary

Hypothesis: Statin therapy will decrease inflammation and slow progression of cardiopulmonary abnormalities in HIV.

Conditions

  • HIV Seropositivity

Interventions

DRUG

Placebo

suger pill manufactured to mimic crestor pills

DRUG

Rouvastatin calcium

Sponsors & Collaborators

  • Alison Morris

    lead OTHER

Principal Investigators

  • Alison M Morris, MD, MS · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2015-11-30
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01881971 on ClinicalTrials.gov